Very few people have a medical reason to skip the COVID-19 vaccine entirely. The only absolute contraindication is a history of severe allergic reaction (anaphylaxis) to a previous dose or to a specific ingredient in the vaccine. Beyond that, certain health situations call for a temporary delay or a switch to a different vaccine type rather than avoiding vaccination altogether.
Severe Allergic Reactions to Vaccine Ingredients
If you’ve had anaphylaxis after a previous COVID-19 vaccine dose, you should not receive the same type of vaccine again. The CDC classifies this as the sole true contraindication. However, you may still be eligible for a different vaccine type. For example, if you had a severe reaction to an mRNA vaccine (Pfizer or Moderna), you could receive the Novavax protein-based vaccine instead, since the two types contain different ingredients.
The ingredient most often suspected in mRNA vaccine reactions is polyethylene glycol, or PEG, a compound used in the fatty coating that protects the mRNA. PEG is common in everyday products like laxatives, cosmetics, and medications, so some people already know they’re sensitive to it. If you have a known PEG allergy, an allergist can help determine whether an mRNA vaccine is safe for you or whether Novavax is the better option. Novavax does not contain PEG but does include polysorbate, a chemically related compound, so that distinction matters if you have allergies to either substance.
A severe allergic reaction to one ingredient does not mean all COVID-19 vaccines are off the table. The key is identifying which component triggered the reaction and choosing a vaccine that doesn’t contain it.
Heart Inflammation After a Previous Dose
Myocarditis or pericarditis (inflammation of the heart muscle or its lining) that develops within three weeks of any COVID-19 vaccine dose is a strong precaution against getting another dose. The CDC advises that people in this situation should generally not receive a subsequent dose of any COVID-19 vaccine.
If, after careful discussion with a doctor, a future dose is considered worthwhile based on individual risk, the episode must be fully resolved first, with no signs of ongoing heart inflammation. Factors that might tip the balance toward vaccinating include older age, underlying conditions that raise the risk of severe COVID-19, or evidence that the myocarditis was actually caused by something other than the vaccine.
Importantly, if your myocarditis or pericarditis occurred before you ever received a COVID-19 vaccine, or if it showed up more than three weeks after a dose, it is not considered a precaution. You can receive any current vaccine once the episode has completely resolved.
Recent COVID-19 Infection
An active COVID-19 infection is a reason to wait, not a reason to skip the vaccine permanently. The CDC says you may delay your vaccine for three months after symptoms started, or three months after a positive test if you had no symptoms. This isn’t a hard rule. You’re allowed to get vaccinated sooner, but waiting gives your body time to benefit from the natural immune response before adding vaccine-generated protection on top of it.
Multisystem Inflammatory Syndrome
Multisystem inflammatory syndrome (MIS) is a rare but serious condition that can follow a COVID-19 infection, mostly in children (MIS-C) but occasionally in adults (MIS-A). If you or your child has had MIS, vaccination is still recommended, but timing matters. The CDC advises waiting at least 90 days after the MIS diagnosis and ensuring full clinical recovery, including a return to normal heart function, before getting vaccinated. In some cases, a care team may decide to vaccinate sooner based on individual circumstances.
Immunocompromised Individuals
Being immunocompromised is not a reason to avoid the vaccine. In fact, it’s a reason to prioritize it, since weakened immune systems raise the risk of severe COVID-19. People who are moderately or severely immunocompromised follow a modified schedule that typically includes additional doses to build adequate protection.
Timing around immunosuppressive treatments does require some planning. Ideally, COVID-19 vaccines should be given at least two weeks before starting or restarting immunosuppressive therapy. For people on treatments that deplete certain immune cells (B cells), the vaccine is best given about four weeks before the next scheduled treatment. That said, the CDC is clear that vaccination should not be delayed just because someone is on immunosuppressive therapy. A less-than-perfect immune response to the vaccine is still better than none.
Age Limits
The current COVID-19 vaccines are approved for everyone aged six months and older. Infants under six months are not eligible. For previously unvaccinated children between six months and four years, the initial series involves multiple doses: three doses of the Pfizer vaccine or two doses of Moderna. Children five and older generally need just one updated dose regardless of their vaccination history, with one exception: unvaccinated individuals aged 12 and up who choose Novavax need two doses.
Dermal Fillers
People with cosmetic dermal fillers, particularly longer-lasting types, have occasionally experienced localized swelling near the filler site after mRNA vaccination. This isn’t a contraindication, but it’s worth knowing about. The swelling is temporary and treatable. If you have fillers and are concerned, the reaction can typically be managed with short courses of anti-inflammatory medication. People who have previously had inflammatory reactions to their fillers may be at slightly higher risk and should mention their filler history before vaccination.
Who Is Actually Ruled Out
The list of people who truly cannot receive any COVID-19 vaccine is extremely short: those with confirmed anaphylaxis to ingredients found in every available vaccine type. Nearly everyone else, including people with allergies, heart conditions, autoimmune diseases, or weakened immune systems, has a safe path to vaccination. It may involve choosing a specific vaccine, adjusting the timing, or working with a specialist, but outright exclusion is rare.